Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses

J. Zhou, Y. L.A. Chau, J. W. Yoo, S. Lee, K. Ng, E. C. Dee, T. Liu, A. K.C. Wai, Q. Zhang, G. Tse

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)e316-e317
JournalClinical Oncology
Issue number7
Publication statusPublished - Jul 2022
Externally publishedYes

Cite this